In 2016, Pfizer and the Institute of Pediatric Innovation (IPI) organized an open innovation competition in hopes of addressing an ongoing challenge: administer multiparticulate medicines to children more easily. HS Design, a design firm specializing in medical devices and life sciences, decided to enter the competition and ended up not only winning the program but taking its innovation further toward commercialization. The experience not only served HS Design, but it also exemplifies how open innovation programs could help launch medical advances.
